Suppr超能文献

氮化锆涂层植入物在全膝关节翻修术中对疑似金属过敏的有益作用。

Beneficial effect of a zirconium-nitride-coated implant in total knee arthroplasty revision for suspected metal hypersensitivity.

机构信息

Service de Chirurgie Orthopédique et Traumatologie, CHU Amiens-Picardie, 80480, Salouël, France.

Service de Chirurgie Orthopédique et Traumatologie, CHU Amiens-Picardie, 80480, Salouël, France.

出版信息

Orthop Traumatol Surg Res. 2022 Sep;108(5):103320. doi: 10.1016/j.otsr.2022.103320. Epub 2022 May 13.

Abstract

INTRODUCTION

Revision of total knee arthroplasty (rTKA) for suspicion of metal hypersensitivity (MHS) may require hypoallergenic implants. Results for coated implants have not been reported. The aim of the present study was to assess short-term results and survival of rTKA for MHS using a multilayer implant coating.

HYPOTHESIS

Multilayer implant coating improves functional results in rTKA, with survival comparable to primary coated implants.

MATERIAL AND METHODS

A single-center retrospective observational study included 28 patients (30 knees) undergoing rTKA for MHS using a coated implant between May 2011 and November 2016. Exclusion criteria comprised implant malpositioning and history of infection in the affected knee. Clinical and radiological results were assessed on the International Knee Society (IKS) and SF-36 functional scores and Ewald radiological score. Survival was calculated on Kaplan-Meier estimation.

RESULTS

Mean follow-up was 3.8 years. Mean IKS score increased by 40.2 points (40%) [range, 28.1-52.3] (p<0.05). Mean range of motion increased by 17° [range, 9.5-24.5°] (p<0.05). Mean physical and mental SF-36 components were respectively 44.7 and 46.1. Survivorship was 93%.

DISCUSSION

There was significant functional improvement after rTKA for MHS. There were no short-term complications related to the zirconium nitrate coating. However, studies with longer follow-up will be needed for confirmation.

LEVEL OF EVIDENCE

IV; retrospective study.

摘要

简介

怀疑金属过敏(MHS)的全膝关节翻修术(rTKA)可能需要低致敏性植入物。涂层植入物的结果尚未报道。本研究的目的是评估使用多层植入物涂层治疗 MHS 的 rTKA 的短期结果和存活率。

假设

多层植入物涂层可改善 rTKA 的功能结果,其存活率可与原发性涂层植入物相媲美。

材料和方法

单中心回顾性观察性研究纳入 2011 年 5 月至 2016 年 11 月期间因 MHS 接受涂层植入物 rTKA 的 28 例患者(30 膝)。排除标准包括植入物位置不当和受影响膝关节感染史。临床和影像学结果采用国际膝关节学会(IKS)和 SF-36 功能评分和 Ewald 影像学评分进行评估。通过 Kaplan-Meier 估计计算生存率。

结果

平均随访 3.8 年。IKS 评分平均增加 40.2 分(40%)[范围,28.1-52.3](p<0.05)。平均活动范围增加 17°[范围,9.5-24.5°](p<0.05)。平均身体和精神 SF-36 成分分别为 44.7 和 46.1。生存率为 93%。

讨论

MHS 的 rTKA 后功能显著改善。与硝酸氧锆涂层无关的短期并发症。然而,需要进行更长时间的随访研究来确认。

证据水平

IV;回顾性研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验